Outlook Therapeutics is trading 5.22% up now at $0.66 after no specific catalyst was provided.
- The available alert does not identify a company announcement, filing, or other event behind the move.
- It also does not confirm whether broader biotech-sector trading contributed to the gain.
- Additional disclosure may be needed to determine what is driving the price change.